Although our EWAS did not focus on the study of SLE patients, small effects of IRF5 methylation on kidney-related outcomes, mediated at least partially by its expression and subsequent IFN pathways, might be detected as effects on eGFR in the general population. Here, IFNA1 is linked to systemic lupus erythematosus.